However, this result does not rule out the possibility that chronic anti-VEGF therapy might promote macular atrophy, because histopathological studies have demonstrated that choroidal vascular depletion is present in early AMD and is progressive in advanced AMD.13 This evidence concerns the gene VEGFA and age-related macular degeneration.